Literature DB >> 14645336

Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients.

Wendy S Biggs1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645336     DOI: 10.3122/jabfm.16.5.455

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


× No keyword cloud information.
  7 in total

Review 1.  Drug-induced hypoglycaemia: an update.

Authors:  Chaker Ben Salem; Neila Fathallah; Houssem Hmouda; Kamel Bouraoui
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

Review 2.  Gatifloxacin: a review of its use in the treatment of bacterial infections in the US.

Authors:  Susan J Keam; Katherine F Croom; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  An evaluation of the effects of gatifloxacin on glucose homeostasis.

Authors:  Ahunna J Onyenwenyi; Almut G Winterstein; Randy C Hatton
Journal:  Pharm World Sci       Date:  2008-02-23

4.  Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.

Authors:  Sunil K Vooturi; Rajendra S Kadam; Uday B Kompella
Journal:  Mol Pharm       Date:  2012-10-11       Impact factor: 4.939

Review 5.  Dysglycaemias and fluoroquinolones.

Authors:  Roshan J Lewis; John F Mohr
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Gatifloxacin-induced severe hyperglycaemia and ketoacidosis in a non-diabetic renal transplant recipient.

Authors:  Ambar Khaira; Ankur Gupta; Nikhil Tandon; Sanjay K Agarwal
Journal:  Clin Exp Nephrol       Date:  2008-07-17       Impact factor: 2.801

7.  Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia.

Authors:  Wissam K Kabbara; Wijdan H Ramadan; Peggy Rahbany; Souhaila Al-Natour
Journal:  Ther Clin Risk Manag       Date:  2015-04-22       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.